The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELRX PHARMACEUTICALS INC | COM | 00444T100 | 84 | 21,870 | SH | SOLE | 21,870 | 0 | 0 | ||
AGILE THERAPEUTICS INC | COM | 00847L100 | 248 | 26,736 | SH | SOLE | 26,736 | 0 | 0 | ||
AMERICAN CAP LTD | COM | 02503Y103 | 962 | 65,055 | SH | SOLE | 65,055 | 0 | 0 | ||
BLACKROCK FLOAT RATE OME STR | COM | 09255X100 | 152 | 10,958 | SH | SOLE | 10,958 | 0 | 0 | ||
BLACKSTONE GSO LNG SHRT CR I | COM SHS BN INT | 09257D102 | 224 | 13,909 | SH | SOLE | 13,909 | 0 | 0 | ||
CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 5,549 | 2,246,469 | SH | SOLE | 2,246,469 | 0 | 0 | ||
EATON VANCE SR INCOME TR | SH BEN INT | 27826S103 | 297 | 45,659 | SH | SOLE | 45,659 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 340 | 3,671 | SH | SOLE | 3,671 | 0 | 0 | ||
ESTERLINE TECHNOLOGIES CORP | COM | 297425100 | 813 | 7,107 | SH | SOLE | 7,107 | 0 | 0 | ||
MEDLEY CAP CORP | COM | 58503F106 | 292 | 31,961 | SH | SOLE | 31,961 | 0 | 0 | ||
MEDLEY MGMT INC | CL A COM | 58503T106 | 305 | 27,760 | SH | SOLE | 27,760 | 0 | 0 | ||
NUVEEN SR INCOME FD | COM | 67067Y104 | 198 | 29,777 | SH | SOLE | 29,777 | 0 | 0 | ||
PIONEER FLOATING RATE TR | COM | 72369J102 | 382 | 32,874 | SH | SOLE | 32,874 | 0 | 0 | ||
PROSPECT CAPITAL CORPORATION | COM | 74348T102 | 309 | 36,527 | SH | SOLE | 36,527 | 0 | 0 | ||
REGADO BIOSCIENCES INC | COM | 75874Q107 | 14 | 11,327 | SH | SOLE | 11,327 | 0 | 0 | ||
RELYPSA INC | COM | 759531106 | 405 | 11,210 | SH | SOLE | 11,210 | 0 | 0 | ||
SENSATA TECHNOLOGIES HLDG NV | SHS | N7902X106 | 611 | 10,634 | SH | SOLE | 10,634 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 571 | 2,532 | SH | Put | SOLE | 2,532 | 0 | 0 | |
SYNTA PHARMACEUTICALS CORP | COM | 87162T206 | 71,893 | 37,058,136 | SH | SOLE | 37,058,136 | 0 | 0 | ||
TICC CAPITAL CORP | COM | 87244T109 | 164 | 23,742 | SH | SOLE | 23,742 | 0 | 0 |